27 May 2022
Treatments and vaccines for Covid-19 – EMA regular press briefing on Covid-19
On 2 June 2022, the European Medicines Agency (EMA) is holding a regular press briefing on Covid-19. There is a live broadcast from 14:30 to 15:00 Amsterdam time (CEST) with speakers such as Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy) and Georgy Genov (Head of Pharmacovigilance).
For more information, see here.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Swissmedic: Haemovigilance Annual Report 2025
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
Swissmedic: Revision of the Guidance document Authorisation Biosimilar